Connect with us
Neuraxpharm aims for €500 million in net sales in 2024, up 13.6% from €440 million last year, driven by its focus on CNS disorder treatments. Acquisitions,...
Boehringer Ingelheim reached a sales figure of €24.1 billion in 2022, which translates into a year-on-year rise of 10.5%. In 2022, the Spanish subsidiary registered an...
In ten years since its inception, Moderna has transformed from a research-stage company advancing programs in the messenger RNA (mRNA) field to a company with a...